The dependence of virus activation and inactivation on SCM concentration was particularly evident in the biphasic dose-effect curves associated with HIV-1(YU2) infection of CD4− CCR5+ target cells (Figure 1A and 1B and Figure S5). The gene discussed is CD4; the disease is infection.